✦ LIBER ✦

US biotech and pharma patent examination

Book ID: 103623344
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 55 KB
Volume: 18
Category: Article
ISSN: 0172-2190
DOI: 10.1016/0172-2190(96)84658-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enabling TRIPs: The pharma–biotech–unive

Enabling TRIPs: The pharma–biotech–university patent coalition

✍ Tyfield, David 📂 Article 📅 2008 🏛 Taylor and Francis Group 🌐 English ⚖ 199 KB

Recent US patent legislation: What's new

Recent US patent legislation: What's new for biotech?

✍ Gogoris, Adda C.; Todaro, John C. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Biotech and pharma face more costly clin

Biotech and pharma face more costly clinical trials

✍ Brower, Vicki 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

Productivity and attrition: key challeng

Productivity and attrition: key challenges for biotech and pharma

✍ Swami Subramaniam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Marina Biotech Inc announces allowance o

Marina Biotech Inc announces allowance of fundamental RNAi delivery patent from US Patent Office

📂 Article 📅 2010 🏛 Elsevier Science ⚖ 50 KB

personal product companies with global headquarters outside the USA is UK firm Unilever with sales of $26.3 bn. The firms were ranked based on sales of household, personal care and beauty products during their most recently concluded fiscal year. Unilever saw volume and underlying sales increase by

Insights into US public biotech sector u

Insights into US public biotech sector using patenting trends

✍ Aggarwal, Saurabh; Gupta, Vinay; Bagchi-Sen, Sharmistha 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 316 KB